SB012 for the treatment of active ulcerative colitis: a clinical study in early development (phase IIa), conducted in several study centres, with random assignment of patients to active treatment or placebo, to investigate the efficacy, pharmacokinetics, tolerability, and safety of SB012 enema administered once daily SB012for the treatment of active ulcerative colitis: a clinical study in early development (phase II ...
SB012 for the treatment of active ulcerative colitis (SECURE): a prospective, multi-centre, randomised, double-blind, placebo-controlled phase IIa clinical trial to evaluate the efficacy, pharmacokinetics, tolerability, and safety of SB012 enema administered once daily - SECURE SB012for the treatment of active ulcerative colitis (SECURE): a prospective, multi-centre, randomise ...
Active ulcerative colitis;Therapeutic area: Body processes [G] - Digestive System and Oral Physiological Phenomena [G10] Active ulcerative colitis;Therapeutic area: Body processes [G] - Digestive System and Oral Physiolog ...
Efficacy, Pharmacokinetics, Tolerability, Safety of SB012 Intrarectally Applied in Active Ulcerative Colitis Patients Efficacy, Pharmacokinetics, Tolerability, Safety of SB012Intrarectally Applied in Active Ulcerative ...
SB012 for Treatment of Active Ulcerative Colitis: Prospective Multi-centre Randomised Double-blind Placebo-controlled Phase IIa Clinical Trial to Evaluate Efficacy, Pharmacokinetics, Tolerability and Safety of SB012 Enema Administered OD SB012for Treatment of Active Ulcerative Colitis: Prospective Multi-centre Randomised Double-blind Pl ...